APA

Agarwal R., Gourley C., Perren T. J., Reed N., Parkin D. E., Carty K., Rustin G. J. S., Gabra H., Paul J., Gore M. E. & Kaye S. B. (20101129). First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series. : European journal of cancer (Oxford, England : 1990).

Chicago

Agarwal Roshan, Gourley Charlie, Perren Timothy J, Reed Nicholas, Parkin David E, Carty Karen, Rustin Gordon J S, Gabra Hani, Paul Jim, Gore Martin E and Kaye Stanley B. 20101129. First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series. : European journal of cancer (Oxford, England : 1990).

Harvard

Agarwal R., Gourley C., Perren T. J., Reed N., Parkin D. E., Carty K., Rustin G. J. S., Gabra H., Paul J., Gore M. E. and Kaye S. B. (20101129). First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series. : European journal of cancer (Oxford, England : 1990).

MLA

Agarwal Roshan, Gourley Charlie, Perren Timothy J, Reed Nicholas, Parkin David E, Carty Karen, Rustin Gordon J S, Gabra Hani, Paul Jim, Gore Martin E and Kaye Stanley B. First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC series. : European journal of cancer (Oxford, England : 1990). 20101129.